Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Angiodynamic Inc (NASDAQ: ANGO) closed the day trading at $6.37 down -16.73% from the previous closing price of $7.65. In other words, the price has decreased by -$16.73 from its previous closing price. On the day, 2.24 million shares were traded. ANGO stock price reached its highest trading level at $7.04 during the session, while it also had its lowest trading level at $6.185.
Ratios:
For a better understanding of ANGO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 2.25. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On September 25, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $19.
Raymond James Downgraded its Strong Buy to Outperform on April 17, 2023, whereas the target price for the stock was revised from $14 to $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 08 ’24 when Clemmer James C bought 10,000 shares for $6.70 per share. The transaction valued at 67,000 led to the insider holds 539,066 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANGO now has a Market Capitalization of 258839856 and an Enterprise Value of 237973856. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.88 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 0.783 whereas that against EBITDA is -16.651.
Stock Price History:
The Beta on a monthly basis for ANGO is 0.66, which has changed by -0.09900987 over the last 52 weeks, in comparison to a change of 0.32295227 over the same period for the S&P500. Over the past 52 weeks, ANGO has reached a high of $8.25, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is -15.38%, while the 200-Day Moving Average is calculated to be -2.47%.
Shares Statistics:
Over the past 3-months, ANGO traded about 495.21K shares per day on average, while over the past 10 days, ANGO traded about 579720 shares per day. A total of 40.43M shares are outstanding, with a floating share count of 38.24M. Insiders hold about 5.88% of the company’s shares, while institutions hold 79.52% stake in the company. Shares short for ANGO as of 1726185600 were 1245840 with a Short Ratio of 2.52, compared to 1723680000 on 1389305. Therefore, it implies a Short% of Shares Outstanding of 1245840 and a Short% of Float of 3.95.
Earnings Estimates
Investors are keenly observing as 3.0 analysts analyze and rate the current performance of Angiodynamic Inc (ANGO) in the stock market.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.09 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.4 and -$0.41 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.11, with 2.0 analysts recommending between $0.0 and -$0.23.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $70.9M. There is a high estimate of $71.5M for the next quarter, whereas the lowest estimate is $70.3M.
A total of 3 analysts have provided revenue estimates for ANGO’s current fiscal year. The highest revenue estimate was $285M, while the lowest revenue estimate was $283.4M, resulting in an average revenue estimate of $284.37M. In the same quarter a year ago, actual revenue was $303.91MBased on 2 analysts’ estimates, the company’s revenue will be $308.31M in the next fiscal year. The high estimate is $310.62M and the low estimate is $306M.
